Breaking Down the Barriers to Functional Foods, Nutraceuticals and Claims

Nutraceutical and Functional Food Regulations in the United States and Around the World

Volumn , Issue , 2008, Pages 81-108

  Burdock, George A ^a   Carabin, Ioana G ^a  

^a Burdock Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884464945     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012373901-8.00007-X     Document Type: Chapter

References (15)

1. Rowe SB Round table forum, moderators comments. What is a nutrient? Defining the food-drug continuum 1999, Georgetown University.
2. Anonymous (1999). Executive Summary. In What is a nutrient? Defining the food-drug continuum. Georgetown University, Center for Food and Nutrition Policy. Proceedings of a Symposium, Ceres Forum, March 30.
3. Rulis A. (2005). Food safety and nutritional risk. Bioactive food components. CSL/JIFSAN Symposium on Food Safety and Nutrition. July.
4. Bailey R Functional foods In Japan: FOSHU (foods for specific health uses) and foods with nutrient function claims. Regulation of functional foods and nutraceuticals 2005, 247-261. Blackwell Publishing, Ames. C. Hasler. (Ed.).
5. Burdock GA, Carabin IC Generally recognized as safe (GRAS): history and description. Toxicol Lett 2004, 150:3-18.
6. Carabin IG The clinical aspects of claim substantiation: clinical trial costs. FDLI Update 2004, 4:39-43.
7. Carabin IG The clinical aspects of claim substantiation: inclusion/exclusion criteria, screening and baseline evaluations in clinical trials. FDLI Update 2004, 5:41-45.
8. International Food Information Council (IFIC) (2005). Qualified health claims consumer research project executive summary (site visited 25 Dec 05). http://www.ific.org/research/qualhealthclaimsres.cfm.
9. Burdock GA Dietary supplements and lessons to be learned from GRAS. J Regulat Toxicol Pharmacol 2000, 31:68-76.
10. Council for Agricultural Science and Technology (CAST) (2003). Issue Paper No. 24, Nutraceuticals for health promotion and disease prevention. Camire, ME (chair). CAST, Ames, IA, 16 pages.
11. Hutt PB U.S. Government regulations of food with claims for sepcial physiological value. Essentials of functional foods 2000, 339-362. Aspen Publishers, Inc., Gaithersburg. K. Schmidl, T. Labuza (Eds.).
12. Kracov DA, Rubin PD, Dwyer LM Dietary supplements and drug constituents: the Pharmanex v. Shalala case and implications for the pharmaceutical and dietary supplement industries. Regulation of functional foods and nutraceuticals 2005, 137-148. Blackwell Publishing, Ames. C. Hasler (Ed.).
13. Walsh EM, Leitzan EK, Hutt PB The importance of the court decision in Pearson v. Shalala to the marketing of conventional food and dietary supplements in the United States. Regulation of functional foods and nutraceuticals 2005, 109-135. Blackwell Publishing, Ames. C. Hasler (Ed.).
14. Griffiths J.C. The value of playing it safe. Function Foods Nutraceut 2005, Nov.:24-28.
15. Talati AR New dietary Ingredient Notifications: A comprehensive Review and strategies for avoiding FDA objections. Food and Drug Law Journal 2007, 247-398. Blackwell Publishing, Ames. C. Hasler (Ed.).